Long-term outcome and prognostic factors of surgically treated thymic carcinoma: Results of 306 cases from a Japanese nationwide database study

European Journal of Cardio-thoracic Surgery

Volumn 49, Issue 3, 2016, Pages 835-841

  Hishida, Tomoyuki ^a   Nomura, Shogo ^b   Yano, Motoki ^c   Asamura, Hisao ^a,d   Yamashita, Motohiro ^e   Ohde, Yasuhisa ^f   Kondo, Keishi ^g   Date, Hiroshi ^h   Okumura, Meinoshin ⁱ   Nagai, Kanji ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b Center for Research Administration and Support   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e National Hospital Organization   (Japan)

^f SHIZUOKA CANCER CENTER   (Japan)

^g HOKKAIDO CANCER CENTER   (Japan)

^h KYOTO UNIVERSITY   (Japan)

ⁱ OSAKA UNIVERSITY   (Japan)

Author keywords

Masaoka stage; Radiation therapy; Resection status; Surgery; Thymic carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EPITHELIUM TUMOR; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THYMUS CANCER; TREATMENT OUTCOME; JAPAN; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROGNOSIS; RECURRENT DISEASE; THYMOMA; THYMUS NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84962816220     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezv239     Document Type: Article

References (25)

1. Kondo K, Monden Y. Therapy for thymic epithelial tumours: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-84; discussion 84-5
2. Marx A, Rieker R, Toker A, Langer F, Strobel P. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. Thorac Surg Clin 2011;21:25-31. v-vi
3. Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W et al. Thymic carcinoma: a cohort study of patients from the European Society of Thoracic Surgeons Database. J Thorac Oncol 2014;9:541-48
4. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 1991;67:1025-32
5. Tseng YL, Wang ST, Wu MH, Lin MY, Lai WW, Cheng FF. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg 2003;76:1041-5
6. Chalabreysse L, Etienne-Mastroianni B, Adeleine P, Cordier JF, Greenland TThivolet-Bejui F. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology 2004;44:367-74
7. Yano M, Sasaki H, Yokoyama T, Yukiue H, Kawano O, Suzuki S et al. Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol 2008;3: 265-9
8. Lee CY, Bae MK, Park IK, Kim DJ, Lee JG, Chung KY. Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution. Eur J Cardiothorac Surg 2009;36: 159-62; discussion 63
9. Huang J, Rizk NP, Travis WD, Riely GJ, Park BJ, Bains MS et al. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 2009;138:26-31
10. Okereke IC, Kesler KA, Freeman RK, Rieger KM, Birdas TJ, Ascioti AJ et al. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg 2012;93:1668-72; discussion 72-3
11. Muller-Hermelink HK, Engel P, Kuo TT, Strobel P, Marx A, Harris NL. Tumours of the thymus: introduction. In: Travis W, Brambilla E, Muller-Hermelink HK et al. (eds). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press; 2004, 148
12. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48: 2485-92
13. Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol 2010;5:2017-23
14. Weksler B, Dhupar R, Parikh V, Nason KS, Pennathur A, Ferson PF. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 2013;95:299-303
15. Ahmed U, Yao X, Detterbeck F, Huang J, Filosso PL, Ruffini E et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg 2015;149:95-101
16. Detterbeck F, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C et al. The IASLC/ITMIG Thymic Epithelial Tumours Staging Project: proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumours. J Thorac Oncol 2014;9:S65-72
17. Agatsuma T, Koizumi T, Kanda S, Ito M, Urushihata K, Yamamoto H et al. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma. J Thorac Oncol 2011;6:2130-4
18. Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol 2011;29:2060-5
19. Inoue A, Sugawara S, Harada M, Kobayashi K, Kozuki T, Kuyama S et al. Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma: North Japan Lung Cancer group study 0803. J Thorac Oncol 2014;9:1805-9
20. Detterbeck F, Youssef S, Ruffini E, Okumura M. A review of prognostic factors in thymic malignancies. J Thorac Oncol 2011;6:S1698-704
21. Venuta F, Anile M, Diso D, Vitolo D, Rendina EA, De Giacomo T et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 2010;37:13-25
22. Korst RJ, Bezjak A, Blackmon S, Choi N, Fidias P, Liu G et al. Neoadjuvant chemoradiotherapy for locally advanced thymic tumours: a phase II, multiinstitutional clinical trial. J Thorac Cardiovasc Surg 2014;147:36-44, 46.e1
23. Omasa M, Date H, Sozu T, Sato T, Nagai K, Yokoi K et al. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II-III thymic epithelial tumours: the Japanese Association for Research on the Thymus Database Study. Cancer 2015;121:1008-16
24. Onuki T, Ishikawa S, Yamamoto T, Ito H, Sakai M, Onizuka M et al. Pathologic radioresponse of preoperatively irradiated invasive thymomas. J Thorac Oncol 2008;3:270-6
25. Komaki R, Gomez DR. Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive. Front Oncol 2014;3:330